Login

Bafna Pharmaceuticals Ltd.

₹172.72

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Bafna Pharmaceuticals Ltd.

  • NSE : BAFNAPH
Add Alert
Add Watchlist

₹172.72

₹172.72

-3.53 (-2.0%) - 2 Oct 2025 04:25 PM
  • NSE : BAFNAPH

About Company

Bafna Pharmaceuticals Ltd is engaged in the production of tablets , capsule and oral syrup. The company is currently focusing on prescription drugs in the global market and contract manufacturing and dossier filing in regulated markets.Their product range includes Antibacterials,Antipyretics,Anticonvulsants,Anxiolytics,Pain management,Anthelmintics,Antifungal,Appetite stimulants,Antidiarrhoeals,Antiemetics,Hypnotics,Antacids and antiulcerants,Vitamin and dietery preparation,Cough and cold preparations,Antiasthmatics,Calcium preparations,Antihypertensives& Antidiabetics

Market Cap. ₹ 409 Cr.
52 Week - High/Low ₹ 95/69
P/E Ratio 49.49
P/B Ratio 4.82
Enterprise Value ₹ 422 Cr.
ROE % 5.01
RSI Value 79.92
EMA 50 118.5
EMA 200 93.06
Market Cap. ₹ 409 Cr.
52 Week - High/Low ₹ 95/69
P/E Ratio 68.00
P/B Ratio N/A
Enterprise Value ₹ 403 Cr.
ROE % -25.42
RSI Value 79.92
EMA 50 118.5
EMA 200 93.06
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.